Pidotimod
From Wikipedia, the free encyclopedia
|
Pidotimod
|
|
| Systematic (IUPAC) name | |
| (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | L03 |
| PubChem | |
| Chemical data | |
| Formula | C9H12N2O4S |
| Mol. mass | 244.26758 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pidotimod is an immunostimulant.
|
|||||||||||||||||

